Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

A critical evaluation of Quintner et al: Missing the point.

Dommerholt J, Gerwin RD.

J Bodyw Mov Ther. 2015 Apr;19(2):193-204. doi: 10.1016/j.jbmt.2015.01.009. Epub 2015 Feb 4. Review.

PMID:
25892372
2.

Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.

OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith MJ, Sibony P, Plumb K, Wang JK, Werner JS.

Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8173-9. doi: 10.1167/iovs.14-14961.

PMID:
25370513
3.

Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.

OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS.

Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8180-8. doi: 10.1167/iovs.14-14960.

PMID:
25370510
4.

Pneumothorax complication of deep dry needling demonstration.

Cummings M, Ross-Marrs R, Gerwin R.

Acupunct Med. 2014 Dec;32(6):517-9. doi: 10.1136/acupmed-2014-010659. Epub 2014 Sep 19. No abstract available.

PMID:
25239239
5.

Diagnosis of myofascial pain syndrome.

Gerwin RD.

Phys Med Rehabil Clin N Am. 2014 May;25(2):341-55. doi: 10.1016/j.pmr.2014.01.011. Epub 2014 Mar 18. Review.

PMID:
24787337
6.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ.

JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312.

7.

The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group.

JAMA Neurol. 2014 Jun;71(6):693-701. doi: 10.1001/jamaneurol.2014.133.

PMID:
24756302
8.

The idiopathic intracranial hypertension treatment trial: design considerations and methods.

Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ, Wall M; NORDIC IIHTT Study Group.

J Neuroophthalmol. 2014 Jun;34(2):107-17. doi: 10.1097/WNO.0000000000000114.

PMID:
24739993
9.

Reply to Quintner and Cohen.

Gerwin RD.

Pain Med. 2014 Apr;15(4):720-2. doi: 10.1111/pme.12393. No abstract available.

PMID:
24716592
10.

Three-dimensional computerized mobilization of the cervical spine for the treatment of chronic neck pain: a pilot study.

River Y, Aharony S, Bracha J, Levital T, Gerwin R.

Pain Med. 2014 Jul;15(7):1091-9. doi: 10.1111/pme.12329. Epub 2014 Jan 8.

PMID:
24400987
11.

Diagnosing fibromyalgia and myofascial pain syndrome: a guide.

Gerwin RD.

J Fam Pract. 2013 Dec;62(12 Suppl 1):S19-25. No abstract available.

PMID:
24340342
12.

Are peripheral pain generators important in fibromyalgia and chronic widespread pain?

Gerwin R.

Pain Med. 2013 Jun;14(6):777-8. doi: 10.1111/pme.12169. No abstract available.

PMID:
23786554
13.

Botulinum toxin treatment of myofascial pain: a critical review of the literature.

Gerwin R.

Curr Pain Headache Rep. 2012 Oct;16(5):413-22. doi: 10.1007/s11916-012-0287-6. Review.

PMID:
22777564
14.

A framework for fibromyalgia management for primary care providers.

Arnold LM, Clauw DJ, Dunegan LJ, Turk DC; FibroCollaborative.

Mayo Clin Proc. 2012 May;87(5):488-96. doi: 10.1016/j.mayocp.2012.02.010. Review.

15.

New journal section on musculoskeletal pain.

Gerwin RD.

Pain Med. 2011 Nov;12(11):1655-6. doi: 10.1111/j.1526-4637.2011.01271.x. No abstract available.

PMID:
22099062
16.

The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States.

Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G.

Health Qual Life Outcomes. 2011 Aug 22;9:71. doi: 10.1186/1477-7525-9-71.

17.

Treatment of chronic migraine headache with onabotulinumtoxinA.

Gerwin R.

Curr Pain Headache Rep. 2011 Oct;15(5):336-8. doi: 10.1007/s11916-011-0202-6. Review.

PMID:
21547527
18.

Improving the recognition and diagnosis of fibromyalgia.

Arnold LM, Clauw DJ, McCarberg BH; FibroCollaborative.

Mayo Clin Proc. 2011 May;86(5):457-64. doi: 10.4065/mcp.2010.0738. Review.

19.

Fibromyalgia tender points at examination sites specified by the American College of Rheumatology criteria are almost universally myofascial trigger points.

Gerwin RD.

Curr Pain Headache Rep. 2011 Feb;15(1):1-3. doi: 10.1007/s11916-010-0154-2. No abstract available.

PMID:
20978951
20.

Incidence of myofascial pain syndrome in breast cancer surgery: a prospective study.

Torres Lacomba M, Mayoral del Moral O, Coperias Zazo JL, Gerwin RD, Goñí AZ.

Clin J Pain. 2010 May;26(4):320-5. doi: 10.1097/AJP.0b013e3181c4904a.

PMID:
20393267
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk